Nicole LaBrosse, SVP, CFO: Halozyme Therapeutics HALO Sell · Filed 24/07/23

Trade details

Type: Insider sale
Amount: $215,830.8
Shares · price: 4,008 sh · $53.85 a share
Held after: 15,480 sh
Stock: Halozyme Therapeutics HALO
Person: Nicole LaBrosseSVP, CFO
Trade date: 24/07/22
Filed: 24/07/23
Days to filing: 1 days

Sold 20.6% of holdings

Share of holding sold: 20.6%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/22~24/08/21

Nicole LaBrosse's recent trades

Nicole LaBrosseSVP, CFO
Planned saleHalozyme Therapeutics
Planned sale
Halozyme Therapeutics
HALO
$986.6K
14,700 sh
$986.6K
Filed 05/15
Traded 05/15
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$148.9K
1,913 sh
$148.9K
Filed 25/09/23
Traded 25/09/22
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$24.7K
314 sh
$24.7K
Filed 25/09/23
Traded 25/09/22
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$1M
13,240 sh
$1M
Filed 25/09/11
Traded 25/09/10
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$509K
6,760 sh
$509K
Filed 25/09/11
Traded 25/09/10

Nicole LaBrosse, CFO — sold $215.8K of Halozyme Therapeutics HALO · 20.6% of holdings · 10b5-1 plan | Whalegun